{"id":27974,"date":"2024-10-29T16:30:45","date_gmt":"2024-10-29T15:30:45","guid":{"rendered":"https:\/\/ggba.swiss\/?p=27974"},"modified":"2024-10-29T16:30:47","modified_gmt":"2024-10-29T15:30:47","slug":"ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/","title":{"rendered":"Ikerian secures USD 8 million and a strategic partnership with Sanoptis"},"content":{"rendered":"\n

Ikerian AG, the parent company of RetinAI<\/a>, has raised USD 8 million in the first tranche of its Series B financing round led by new investor Sanoptis<\/a>. The funding will be used to further develop Ikerian’s Discovery CONNECT platform, a clinical solution designed to streamline and automate the management of imaging data in ophthalmology clinics. Alongside the investment, Sanoptis – a leading European ophthalmology network with over 420 clinic locations – has entered into a commercial agreement with Ikerian to integrate RetinAI Discovery’s AI-driven platform into its clinics to support large-scale data management and improve patient care.<\/p>\n\n\n\n

Founded in 2017, Ikerian and its subsidiary RetinAI are at the forefront of AI-powered solutions for ophthalmology. RetinAI’s Discovery platform, which has already received both FDA 510(k) and CE certification, provides advanced data and image analysis powered by machine learning. With partnerships from major healthcare companies such as Boehringer Ingelheim, Novartis and J&J, RetinAI’s platform has steadily gained traction as an essential tool for managing clinical workflows and data transfer in ophthalmology.<\/p>\n\n\n\n

Building on this foundation, the new funds will accelerate the development of Discovery CONNECT, innovative software designed to securely and efficiently transfer imaging data across clinical networks. Scheduled for release in early 2025, Discovery CONNECT aims to simplify clinical workflows, anonymize data, and reduce manual processing to support real-world evidence generation and optimize clinical trial recruitment.<\/p>\n\n\n\n

This investment follows a USD 6.18 million Series A extension round earlier in 2024<\/a>, which enabled Ikerian to expand RetinAI\u2019s Real-World Evidence (RWE) database and enhance its AI capabilities in ophthalmology and neurodegenerative diseases. The company is now looking to expand into new areas, including oculomics, with applications in vascular disease and rare diseases.<\/p>\n\n\n\n

As part of the commercial agreement, Sanoptis will distribute the Discovery platform to selected clinics within its network. “This partnership with Ikerian marks a significant step in transforming ophthalmology practice,\u201d commented Sanoptis CEO Volker Wendel. \u201cTogether, we aim to empower clinicians, enhance workflow efficiency, and ultimately improve patient outcomes.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

Ikerian has raised USD 8 million in Series B funding to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics. Lead investor Sanoptis has entered a strategic partnership to distribute the platform across its European network.<\/p>\n","protected":false},"author":6,"featured_media":27975,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[893,930,894,964,911],"class_list":["post-27974","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-artificial-intelligence","tag-digital-health","tag-financing","tag-imaging","tag-pharma"],"acf":[],"yoast_head":"\nIkerian secures USD 8M and a strategic partnership with Sanoptis<\/title>\n<meta name=\"description\" content=\"Ikerian has raised USD 8 million to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ikerian secures USD 8M and a strategic partnership with Sanoptis\" \/>\n<meta property=\"og:description\" content=\"Ikerian has raised USD 8 million to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-29T15:30:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-29T15:30:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1178\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Ikerian secures USD 8 million and a strategic partnership with Sanoptis\",\"datePublished\":\"2024-10-29T15:30:45+00:00\",\"dateModified\":\"2024-10-29T15:30:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/\"},\"wordCount\":339,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Financing\",\"Imaging\",\"Pharma\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/\",\"url\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/\",\"name\":\"Ikerian secures USD 8M and a strategic partnership with Sanoptis\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\",\"datePublished\":\"2024-10-29T15:30:45+00:00\",\"dateModified\":\"2024-10-29T15:30:47+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Ikerian has raised USD 8 million to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\",\"width\":1178,\"height\":811,\"caption\":\"In research and clinical practice, a lack of data structure and accessibility limits valuable knowledge necessary for decision making. Ikerian has developed an AI powered data management platform to process visual data at scale across multiple data sources efficiently. | \u00a9 Ikerian\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ikerian secures USD 8 million and a strategic partnership with Sanoptis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ikerian secures USD 8M and a strategic partnership with Sanoptis","description":"Ikerian has raised USD 8 million to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/","og_locale":"en_US","og_type":"article","og_title":"Ikerian secures USD 8M and a strategic partnership with Sanoptis","og_description":"Ikerian has raised USD 8 million to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics.","og_url":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-10-29T15:30:45+00:00","article_modified_time":"2024-10-29T15:30:47+00:00","og_image":[{"width":1178,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Ikerian secures USD 8 million and a strategic partnership with Sanoptis","datePublished":"2024-10-29T15:30:45+00:00","dateModified":"2024-10-29T15:30:47+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/"},"wordCount":339,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","keywords":["Artificial Intelligence","Digital Health","Financing","Imaging","Pharma"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/","url":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/","name":"Ikerian secures USD 8M and a strategic partnership with Sanoptis","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","datePublished":"2024-10-29T15:30:45+00:00","dateModified":"2024-10-29T15:30:47+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Ikerian has raised USD 8 million to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","width":1178,"height":811,"caption":"In research and clinical practice, a lack of data structure and accessibility limits valuable knowledge necessary for decision making. Ikerian has developed an AI powered data management platform to process visual data at scale across multiple data sources efficiently. | \u00a9 Ikerian"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Ikerian secures USD 8 million and a strategic partnership with Sanoptis"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/27974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=27974"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/27974\/revisions"}],"predecessor-version":[{"id":27978,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/27974\/revisions\/27978"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/27975"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=27974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=27974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=27974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}